Global Small Molecule API Market to See 7% CAGR to 2027, Expects MRFR in Its New Research Publication Available at MarketPublishers.com
02 Jun 2017 • by Natalie Aster
LONDON – Encouraged by such factors as boosting demand for newly developed small molecules drugs, surging outsourcing trends and uptake in the pharmaceutical industry in emerging countries, among others, the market for small molecule API is expected to follow an upward trend. This market will likely grow from USD 132.9 billion in 2016 to USD 279.7 billion by 2027, exhibiting a healthy CAGR of 7%. Yet, the market growth can be significantly hampered by austerity measures in Europe.
Today, synthetic and chemical API sector remains the largest one in the total marketplace. As of 2016, the sector held the lion’s share (over 81%) of the market.
Geography-wise, North America dominated the market with the largest market share of 38.84% in the year 2016. In the same year, the North American market for small molecule API was reigned by the USA, the country’s market share reached 59.75%.
Market Research Future report titled “Global Small Molecule API market – Estimation & Forecast, 2013-2027” offers a comprehensive analysis of the marketplace, focusing on the current situation in the market and looking at the future possible trends and opportunities. Moreover, the report scrutinizes the market dynamics, examines the growth driving and limiting factors, includes an extensive analysis of the market segmentation (in terms of types, applications, manufacturing methods, regions), provides the Porter’s five forces analysis, etc. Furthermore, a granular review of the competitive environment together with detailed profiles of key players in the market is at hand here. Additionally, this insightful report gives access to forecasts for the market development through 2027.
For other insightful research studies worked out by Market Research Future follow to its page at MarketPublishers.com.